Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice.
about
Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Long-term outcomes of the Atyp ...... th eculizumab as first choice.
@en
Long-term outcomes of the Atyp ...... th eculizumab as first choice.
@nl
type
label
Long-term outcomes of the Atyp ...... th eculizumab as first choice.
@en
Long-term outcomes of the Atyp ...... th eculizumab as first choice.
@nl
prefLabel
Long-term outcomes of the Atyp ...... th eculizumab as first choice.
@en
Long-term outcomes of the Atyp ...... th eculizumab as first choice.
@nl
P2093
P2860
P1433
P1476
Long-term outcomes of the Atyp ...... ith eculizumab as first choice
@en
P2093
Ariane Moyses Bravin
Henrique Mochida Takase
Hong Si Nga
Kelem De Nardi Chagas
Lilian Monteiro Pereira Palma
Mariana Moraes Contti
Rosa Marlene Viero
Trycia Nunes da Silva
P2860
P304
P356
10.1371/JOURNAL.PONE.0188155
P407
P577
2017-11-14T00:00:00Z